A Randomized Phase III Trial Comparing Folfirinox to Gemcitabine in Locally Advanced Pancreatic Carcinoma

Clinical trial NCT02539537 · COMPLETED

Trial details

NCT number: NCT02539537
Sponsor: UNICANCER
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Pancreatic Cancer Carcinoma

Start date: 2015-10-23
Primary completion: 2022-02-01
Enrollment: 171

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.